Chewable anti-reflux tablets with sodium alginate

Published: 7-Oct-2021 Featured companies: JRS Pharma
Ingredients

The formulation example is available to download now

Many anti-reflux medications on the market are available in the form of suspensions containing sodium alginate as the active ingredient. Corresponding tablet formulations are still less common, despite their greater convenience and stability.

The study aimed to develop a chewable anti-reflux tablet by direct compression. A formulation composed of VIVAPHARM® Sodium Alginate PH R5, and the excipients PROSOLV® SMCC 50, EMDEX® and PRUV® was developed, leading to an effective solid dosage form to prevent reflux.

Click here to read more.

Featured companies

JRS Pharma is a first class manufacturer of excipients, offering a complete portfolio of solutions for the nutraceutical and pharmaceutical industries.
See more

You may also like

Ingredients

Introducing the next generation of high functionality excipients

Read more
PROSOLV 730 - Directly compressible carrier for lipophilic ingredients

Trending Articles

  1. Solabia Nutrition's Brainberry incorporated into Flow's cognition-supporting functional chocolate Looking past the headlines, NBR find out more about the nootropic, L-theanine and caffeine-boosted functional food and how enhanced sweet treats are impacting the industry
  2. Mythbusting study highlights the heart health benefits of omega-6 fatty acids A new report has highlighted the benefits of omega-6 intake — specifically linoleic acid — in reducing the risk of cardiovascular disease, type II diabetes and elevated cholesterol levels
  3. Nexira's acacia fibres recognised by NutraStrong's Prebiotic Verified programme The two nutraceuticals are the first acacia-based products to be recognised by the initiative, and are deemed effective at a dose of 10g/day
  4. Activ’Inside’s Belight 3 – a clinically proven solution for hyperpigmentation across all skin types A patented oral skincare ingredient addressing dark spots caused by aging and UV exposure
  5. Vitamin B3 diminishes lung inflammation in COPD patients, study reveals Supplementation with vitamin B3 was found to reduce lung inflammatory biomarkers by up to 63%, while also increasing blood NAD levels in those with COPD

Relevant companies

See more

Upcoming event

Vitafoods India

5–7 February 2025 | Exhibition | Mumbai See all

You may also like

Ingredients

Introducing the next generation of high functionality excipients

PROSOLV 730 - Directly compressible carrier for lipophilic ingredients
Manufacturing

JRS Pharma introduces titanium dioxide-free coating

Ti02 will be banned as a food additive in the EU in 2022, with regulations expected to follow in other regions
Ingredients

JRS PHARMA announces the worldwide availability of VIVAPHARM Pectins

VIVAPHARM Pectins are made from locally sourced fresh citrus peels, with additional dried peels imported to ensure supply security
Ingredients

PROSOLV EASYtab Nutra: The all-in-one excipient composite

Formulators can simplify the production of nutritional tablets while still producing robust formulations
Ingredients

JRS Pharma taps into Chinese market with cDMF filings for excipients portfolio

Ingredients by the German excipient maker have been included in the Chinese Drug Master File with the National Medical Products Administration
Ingredients

JRS Pharma to offer povidone products

Strategic alliance expands company's product portfolio
Ingredients

JRS Pharma introduces new excipient for nutritional products

PROSOLV EASYtab NUTRA (all-in-one, ready-to-use excipient composite)
Subscribe now